RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Dipak Banerjee to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Dipak Banerjee has written about Xenograft Model Antitumor Assays.
Dipak Banerjee
Connection Strength
0.580
Xenograft Model Antitumor Assays
  1. Banerjee A, Martinez JA, Longas MO, Zhang Z, Santiago J, Baksi K, Banerjee DK. N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic. Adv Exp Med Biol. 2015; 842:355-74.
    View in: PubMed
    Score: 0.485
  2. Banerjee A, Lang JY, Hung MC, Sengupta K, Banerjee SK, Baksi K, Banerjee DK. Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. J Biol Chem. 2011 Aug 19; 286(33):29127-29138.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support